Sichuan Dowell Science and Technology Inc. (300535.SZ)
CNY 13.6
(0.44%)
CNY 13.6
(0.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 724.59 Million | 510.38 Million | 629.81 Million | 469.64 Million | 396.34 Million | 356.13 Million |
| Cost of Revenue | 508.63 Million | 366.12 Million | 397.46 Million | 290.35 Million | 207.31 Million | 185.8 Million |
| Gross Profit | 215.96 Million | 144.25 Million | 232.35 Million | 179.29 Million | 189.02 Million | 170.32 Million |
| Operating Expenses | 204.11 Million | 130.56 Million | 152.72 Million | 119.2 Million | 142.16 Million | 122.49 Million |
| Selling, General and Administrative Expenses | 124.53 Million | 56.25 Million | 58.29 Million | 39.67 Million | 65.57 Million | 56.72 Million |
| Research and Development Expenses | 42.36 Million | 29.79 Million | 42.24 Million | 37.47 Million | 39.03 Million | 24.29 Million |
| Other Expenses | 37.21 Million | -12.65 Thousand | 533.85 Thousand | -89.73 Thousand | -39.23 Thousand | -38.25 Thousand |
| Cost and Expenses | 712.75 Million | 496.69 Million | 550.18 Million | 409.55 Million | 349.48 Million | 308.3 Million |
| Operating Income | 11.84 Million | -12.97 Million | 71.13 Million | 57.38 Million | 43.17 Million | 48.42 Million |
| Interest Expense | 8.8 Million | 6.54 Million | 4.33 Million | 948.31 Thousand | 11.07 Thousand | 1.92 Million |
| Income Tax Expense | 7.32 Million | 4.21 Million | 5.97 Million | 1.85 Million | 3.84 Million | 7.14 Million |
| Earnings before Tax | 10.87 Million | -12.98 Million | 71.66 Million | 57.29 Million | 43.13 Million | 48.38 Million |
| Net Income | 28.42 Million | -1.82 Million | 65.83 Million | 57.02 Million | 39.36 Million | 41.4 Million |
| Earnings Per Share Basic | 0.27 | -0.02 | 0.65 | 0.57 | 0.40 | 0.42 |
| Earnings Per Share Diluted | 0.27 | -0.02 | 0.64 | 0.56 | 0.38 | 0.40 |
| Weighted Average Shares Outstanding | 104.84 Million | 103.86 Million | 101.9 Million | 100.74 Million | 99.66 Million | 99.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 104.84 Million | 103.86 Million | 102.61 Million | 101.34 Million | 102.68 Million | 102.41 Million |
| Gross Margin | 0.30 | 0.28 | 0.37 | 0.38 | 0.48 | 0.48 |
| EBIT Margin | 0.08 | 0.08 | 0.18 | 0.20 | 0.18 | 0.19 |
| Profit Margin | 0.04 | -0.00 | 0.10 | 0.12 | 0.10 | 0.12 |
| EBITDA | 61.4 Million | 27.46 Million | 111.28 Million | 87.98 Million | 68.1 Million | 59.24 Million |
| Earnings Before Tax Margin | 0.02 | -0.03 | 0.11 | 0.12 | 0.11 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 181.69 Million | 192.64 Million | 163.78 Million | 207.09 Million | 724.59 Million | 209.13 Million |
| Cost of Revenue | 118.74 Million | 123.44 Million | 106.27 Million | 142.41 Million | 494.93 Million | 144.36 Million |
| Gross Profit | 62.94 Million | 69.19 Million | 57.5 Million | 64.67 Million | 229.66 Million | 64.76 Million |
| Operating Expenses | 73.74 Million | 40.43 Million | 49.74 Million | 48.81 Million | 161.28 Million | 40.8 Million |
| Selling, General and Administrative Expenses | 34.11 Million | 3.3 Million | 31.56 Million | -14.39 Million | - | 52.35 Million |
| Research and Development Expenses | 15.44 Million | 9.08 Million | 12.04 Million | 11.16 Million | - | 12.69 Million |
| Other Expenses | -24.18 Million | 17.93 Thousand | -6.13 Million | -390.84 Thousand | -970.97 Thousand | 111.62 Thousand |
| Cost and Expenses | 192.48 Million | 163.88 Million | 156.01 Million | 191.22 Million | 656.21 Million | 185.16 Million |
| Operating Income | -10.79 Million | 25.49 Million | 7.76 Million | -21.03 Million | 11.84 Million | 18.2 Million |
| Interest Expense | 2.92 Million | 2.62 Million | 2.7 Million | 2.56 Million | 8.43 Million | 1.94 Million |
| Income Tax Expense | -8.68 Million | 6.28 Million | 1.81 Million | -1.08 Million | 7.32 Million | 5.15 Million |
| Earnings before Tax | -10.53 Million | 25.51 Million | 7.93 Million | -21.42 Million | 10.87 Million | 18.31 Million |
| Net Income | -813.80 | 22.22 Million | 7.95 Million | -5.02 Million | 28.42 Million | 18.59 Million |
| Earnings Per Share Basic | - | 0.21 | 0.08 | -0.05 | - | 0.18 |
| Earnings Per Share Diluted | - | 0.21 | 0.08 | -0.05 | - | 0.18 |
| Weighted Average Shares Outstanding | 104.8 Million | 104.84 Million | 104.8 Million | 104.53 Million | 104.55 Million | 104.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 104.8 Million | 104.84 Million | 104.8 Million | 104.53 Million | 104.55 Million | 104.37 Million |
| Gross Margin | 0.35 | 0.36 | 0.35 | 0.31 | 0.32 | 0.31 |
| EBIT Margin | -0.04 | 0.15 | 0.10 | 0.07 | - | 0.11 |
| Profit Margin | -0.00 | 0.12 | 0.05 | -0.02 | 0.04 | 0.09 |
| EBITDA | -7.6 Million | 28.43 Million | 15.98 Million | 14.38 Million | - | 23.21 Million |
| Earnings Before Tax Margin | -0.06 | 0.13 | 0.05 | -0.10 | 0.02 | 0.09 |
300891
2360
000927
LIPPISYS
FBDS
024890